Picoplatin is a cytotoxic platinum compound in clinical development for the treatment of patients with solid tumors. It causes apoptosis (cell death) by binding to DNA and interfering with DNA replication and transcription.
For the treatment of patients with solid tumors.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.